RTsafe and OSL sign agreement for distribution
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy, has signed an exclusive agreement for Oncology Systems Limited (OSL) to distribute its products and services in the UK and Ireland.
OSL science and innovation lead Rob Julian said: “OSL is delighted to partner with RTsafe, whose fully customisable anthropomorphic phantoms and dosimetry services bring unparalleled clinical relevance and precision to patient-specific QA, as well as technique development, commissioning and audit. I look forward to this partnership opening up access to RTsafe’s cutting-edge equipment and services to all UK and Irish departments, bringing with it great benefits in treatment safety and accuracy.”
Read this report on page 5 of the April 2025 issue of RAD Magazine.
